$1.42 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q2 2014. The portfolio turnover from Q1 2014 to Q2 2014 was 56.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MS | Sell | MORGAN STANLEY | $64,660,000 | -10.2% | 2,000,000 | -13.4% | 4.55% | -5.4% |
PCLN | Sell | PRICELINE GRP INC | $45,714,000 | -19.3% | 38,000 | -20.0% | 3.22% | -14.9% |
MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $40,010,000 | +20.2% | 500,000 | -4.8% | 2.82% | +26.6% |
TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $39,446,000 | -26.5% | 752,500 | -25.9% | 2.78% | -22.5% |
FB | Sell | FACEBOOK INCcl a | $38,692,000 | -1.9% | 575,000 | -12.2% | 2.72% | +3.3% |
VRSN | Sell | VERISIGN INC | $38,609,000 | -41.3% | 791,000 | -35.2% | 2.72% | -38.2% |
T107PS | Sell | WRIGHT MED GROUP INC | $35,953,000 | -8.4% | 1,145,000 | -9.4% | 2.53% | -3.5% |
AGN | Sell | ALLERGAN INC | $34,690,000 | -19.0% | 205,000 | -40.6% | 2.44% | -14.6% |
IDIX | Sell | IDENIX PHARMACEUTICALS INC | $11,443,000 | +26.5% | 474,800 | -68.3% | 0.80% | +33.3% |
CWST | Sell | CASELLA WASTE SYS INCcl a | $2,785,000 | -54.4% | 555,933 | -53.5% | 0.20% | -52.0% |
VSTM | Exit | VERASTEM INC | $0 | – | -200,000 | -100.0% | -0.14% | – |
LBTYK | Exit | LIBERTY GLOBAL PLC | $0 | – | -210,000 | -100.0% | -0.57% | – |
LBTYA | Exit | LIBERTY GLOBAL PLC | $0 | – | -210,000 | -100.0% | -0.58% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -55,000 | -100.0% | -1.10% | – |
SC | Exit | SANTANDER CONSUMER USA HDG I | $0 | – | -715,000 | -100.0% | -1.15% | – |
BRKR | Exit | BRUKER CORP | $0 | – | -815,000 | -100.0% | -1.24% | – |
PII | Exit | POLARIS INDS INC | $0 | – | -190,000 | -100.0% | -1.77% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -1,134,538 | -100.0% | -2.19% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -443,544 | -100.0% | -2.43% | – |
VOD | Exit | VODAFONE GROUP PLC NEWspnsr adr no par | $0 | – | -1,139,544 | -100.0% | -2.80% | – |
LLY | Exit | LILLY ELI & CO | $0 | – | -805,000 | -100.0% | -3.16% | – |
MRK | Exit | MERCK & CO INC NEW | $0 | – | -975,000 | -100.0% | -3.70% | – |
SAVE | Exit | SPIRIT AIRLS INC | $0 | – | -1,000,000 | -100.0% | -3.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.